These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24722591)

  • 1. Synthesis and biological evaluation of novel 2-methoxypyridylamino-substituted riminophenazine derivatives as antituberculosis agents.
    Zhang D; Liu Y; Zhang C; Zhang H; Wang B; Xu J; Fu L; Yin D; Cooper CB; Ma Z; Lu Y; Huang H
    Molecules; 2014 Apr; 19(4):4380-94. PubMed ID: 24722591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of less lipophilic riminophenazine derivatives for the treatment of drug-resistant tuberculosis.
    Zhang D; Lu Y; Liu K; Liu B; Wang J; Zhang G; Zhang H; Liu Y; Wang B; Zheng M; Fu L; Hou Y; Gong N; Lv Y; Li C; Cooper CB; Upton AM; Yin D; Ma Z; Huang H
    J Med Chem; 2012 Oct; 55(19):8409-17. PubMed ID: 22931472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic evaluation of structure-activity relationships of the riminophenazine class and discovery of a C2 pyridylamino series for the treatment of multidrug-resistant tuberculosis.
    Liu B; Liu K; Lu Y; Zhang D; Yang T; Li X; Ma C; Zheng M; Wang B; Zhang G; Wang F; Ma Z; Li C; Huang H; Yin D
    Molecules; 2012 Apr; 17(4):4545-59. PubMed ID: 22510605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofazimine analogs with efficacy against experimental tuberculosis and reduced potential for accumulation.
    Lu Y; Zheng M; Wang B; Fu L; Zhao W; Li P; Xu J; Zhu H; Jin H; Yin D; Huang H; Upton AM; Ma Z
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5185-93. PubMed ID: 21844321
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Xu J; Wang B; Fu L; Zhu H; Guo S; Huang H; Yin D; Zhang Y; Lu Y
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30782992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of Riminophenazines against Mycobacterium tuberculosis: A Review of Studies that Might be Contenders for Use as Antituberculosis Agents.
    Bvumbi MV
    ChemMedChem; 2020 Dec; 15(23):2207-2219. PubMed ID: 32844566
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Tanner L; Evans JC; Seldon R; Jordaan A; Warner DF; Haynes RK; Parkinson CJ; Wiesner L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31427302
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and anti-tubercular activity of novel alkyl substituted riminophenazine derivatives.
    Li YL; Zhang CL; Zhang DF; Lu Y; Wang B; Zheng MQ; Li C; Yin DL; Huang HH
    Yao Xue Xue Bao; 2012 Jun; 47(6):745-54. PubMed ID: 22919722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riminophenazine Derivatives as Potential Antituberculosis Agents: Synthesis, Biological, and Electrochemical Evaluations.
    Bvumbi MV; van der Westhuyzen C; Mmutlane EM; Ngwane A
    Molecules; 2021 Jul; 26(14):. PubMed ID: 34299475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of new riminophenazine analogues as antimycobacterial agents against drug-resistant Mycobacterium tuberculosis.
    Zhao X; Mei Y; Guo Z; Si S; Ma X; Li Y; Li Y; Song D
    Bioorg Chem; 2022 Nov; 128():105929. PubMed ID: 35701239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis.
    van Rensburg CE; Jooné GK; Sirgel FA; Matlola NM; O'Sullivan JF
    Chemotherapy; 2000; 46(1):43-8. PubMed ID: 10601797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antituberculosis activities of clofazimine and its new analogs B4154 and B4157.
    Reddy VM; Nadadhur G; Daneluzzi D; O'Sullivan JF; Gangadharam PR
    Antimicrob Agents Chemother; 1996 Mar; 40(3):633-36. PubMed ID: 8851584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapeutic activity of clofazimine and its analogues against Mycobacterium tuberculosis. In vitro, intracellular, and in vivo studies.
    Jagannath C; Reddy MV; Kailasam S; O'Sullivan JF; Gangadharam PR
    Am J Respir Crit Care Med; 1995 Apr; 151(4):1083-6. PubMed ID: 7697235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antituberculosis activity of a novel series of optically active 6-nitro-2,3-dihydroimidazo[2,1-b]oxazoles.
    Sasaki H; Haraguchi Y; Itotani M; Kuroda H; Hashizume H; Tomishige T; Kawasaki M; Matsumoto M; Komatsu M; Tsubouchi H
    J Med Chem; 2006 Dec; 49(26):7854-60. PubMed ID: 17181168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel [1,2]-diamines with antituberculosis activity.
    Meng Q; Luo H; Chen Y; Wang T; Yao Q
    Bioorg Med Chem Lett; 2009 Sep; 19(18):5372-5. PubMed ID: 19682895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and bioevaluation of a novel class of (E)-4-oxo-crotonamide derivatives as potent antituberculosis agents.
    Ren J; Xu J; Zhang G; Xu C; Zhao L; You X; Wang Y; Lu Y; Yu L; Wang J
    Bioorg Med Chem Lett; 2019 Feb; 29(4):539-543. PubMed ID: 30630715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and biological evaluation of novel 4H-chromen-4-one derivatives as antituberculosis agents against multidrug-resistant tuberculosis.
    Zhao W; Wang B; Liu Y; Fu L; Sheng L; Zhao H; Lu Y; Zhang D
    Eur J Med Chem; 2020 Mar; 189():112075. PubMed ID: 31986405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
    Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, and antitubercular activity of 3-amidophenols with 5-heteroatomic substitutions.
    Zhang NN; Tang YX; Qian L; Gao YM; Liu ZY; Zou ZL; Zhang TY; Yan M
    Arch Pharm (Weinheim); 2019 Apr; 352(4):e1800277. PubMed ID: 30698293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of a highly potent novel rifampicin analog by preparing a hybrid of the precursors of the antibiotic drugs rifampicin and clofazimine.
    Saravanan P; Dusthackeer VNA; Rajmani RS; Mahizhaveni B; Nirmal CR; Rajadas SE; Bhardwaj N; Ponnuraja C; Bhaskar A; Hemanthkumar AK; Ramachandran G; Tripathy SP
    Sci Rep; 2021 Jan; 11(1):1029. PubMed ID: 33441878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.